Skip to main content

Table 1 Correlations between JPX and clinical characteristics of 116 lung cancer patients

From: lncRNA JPX/miR-33a-5p/Twist1 axis regulates tumorigenesis and metastasis of lung cancer by activating Wnt/β-catenin signaling

 

n

lncRNA JPX level

χ2 test

P value

Characteristics

 

High

Low

  

Total cases

116

58

58

  

Gender

 Male

66

34

32

0.1406

0.7077

 Female

50

24

26

  

Age (years)

  ≤ 60

40

18

22

0.6105

0.4346

 >60

76

40

36

  

Smoking history

 Yes

47

26

21

0.8942

0.3443

 No

69

32

37

  

Histology

 Adenocarcinoma

84

41

43

0.2015

0.9042

 Squamous carcinoma

26

14

12

  

 Other type

6

3

3

  

Tumor location

 Left

55

24

31

1.694

0.193

 Right

61

34

27

  

Differentiation

 High and moderate

21

11

10

0.05815

0.8095

 Poor

95

47

48

  

Tumor size(cm)

  ≤ 3

84

34

50

11.05

0.0009**

 >3

32

24

8

  

TNM stage

 I + II

87

35

52

13.29

0.0003***

 III + IV

29

23

6

  
  1. †Median expression level was used as cutoff. Low expression of JPX in 116 patients was defined as a value below the 50th percentile, and high above the 50th percentile. P values were acquired by Pearson’s chi-square test. **P < 0.01, ***P < 0.001